February 12, 2021
Feature Articles
30
1/2
Life sciences companies challenged by need to minimize health risks without sacrificing data quality during pandemic.
February 12, 2021
View from Washington
30
1/2
FDA emphasizes importance of inclusion in trials.
February 12, 2021
View from Washington
30
1/2
President unveils lengthy program for combatting COVID-19 immediately following inauguration.
February 12, 2021
Issue PDF
30
1/2
Click the title above for a link to open the Applied Clinical Trials January/February 2021 issue in an interactive PDF format.
February 12, 2021
30
1/2
Co-conveners of the newly formed Decentralized Trials & Research Alliance, Amir Kalali, MD and Craig Lipset discuss the alliance as well as how COVID-19 has impacted the industry.
February 12, 2021
Feature Articles
30
1/2
Non-profit biotech organization Cure Rare Disease utilizes collaboration amidst COVID-19 pandemic to catalyze speed of therapeutic research.
February 12, 2021
From The Editor
30
1/2
A look forward to 2021 for the clinical trials industry.
February 12, 2021
Feature Articles
30
1/2
Hybrid studies, patient-centric tools, and collaborations create big changes for clinical trials and stakeholders during COVID-19.
February 12, 2021
News
30
1/2
A compilation of recent notable news developments that pertain to the clinical trials industry.
February 12, 2021
View from Brussels
30
1/2
Cancer still a primary focus of EMA in light of COVID and vaccine development.
February 12, 2021
Feature Articles
30
1/2
2020 Tufts CSDD – IBM Watson Health benchmarking study highlights need for new functionality from EDC solutions and providers.
February 12, 2021
A Closing Thought
30
1/2
COVID-19 speeds up clinical research and creates new advancements within industry.